ArticleClinical medicine insights. Arthritis and musculoskeletal disorders2022

Open-Label Pilot Study of a Single Intra-Articular Injection of Mannitol-Modified Cross-Linked Hyaluronic Acid (HANOX-M-XL) for the Treatment of the First Metatarsophalangeal Osteoarthritis (Hallux Rigidus): The REPAR Trial.

Laurent Galois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.